Osimertinib in EGFR Mutation–Positive Advanced NSCLC

Jung Y. Choi, Yoon J. Choi, Sang W. Shin

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish
Number of pages1
JournalThe New England journal of medicine
Volume378
Issue number13
DOIs
Publication statusPublished - 2018 Mar 29

Fingerprint

Mutation
osimertinib

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Osimertinib in EGFR Mutation–Positive Advanced NSCLC. / Choi, Jung Y.; Choi, Yoon J.; Shin, Sang W.

In: The New England journal of medicine, Vol. 378, No. 13, 29.03.2018.

Research output: Contribution to journalLetter

@article{a9fb591de24a43cf9732283778773d6a,
title = "Osimertinib in EGFR Mutation–Positive Advanced NSCLC",
author = "Choi, {Jung Y.} and Choi, {Yoon J.} and Shin, {Sang W.}",
year = "2018",
month = "3",
day = "29",
doi = "10.1056/NEJMc1801669",
language = "English",
volume = "378",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "13",

}

TY - JOUR

T1 - Osimertinib in EGFR Mutation–Positive Advanced NSCLC

AU - Choi, Jung Y.

AU - Choi, Yoon J.

AU - Shin, Sang W.

PY - 2018/3/29

Y1 - 2018/3/29

UR - http://www.scopus.com/inward/record.url?scp=85044543156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044543156&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1801669

DO - 10.1056/NEJMc1801669

M3 - Letter

C2 - 29595924

AN - SCOPUS:85044543156

VL - 378

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 13

ER -